Form 4 for ALKS Alkermes plc.
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-18 · accession 0001127602-22-006332 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-02-23 | 2022-02-20+ | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | F - Tax | $25.05 | -8,527 | 30.0K | -22% | -$213.6K |
| DM | 2022-02-23 | 2022-02-20+ | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | — | +29.0K | 19.6K | New | — |
| D | 2022-02-23 | 2022-02-18 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | S - Sale+OE | $25.17 | -2,306 | 9,496 | -20% | -$58.0K |
| DM | 2022-02-23 | 2022-02-20+ | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | M - OptEx | — | -29.0K | 20.2K | -59% | — |
| DM | 2022-02-23 | 2022-02-18 | ALKS | Hopkinson Craig C. | EVP R, D, Chief Medical Off | A - Grant | $0.00 | +174.4K | 139.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-02-20 | F | D | 2,966 | $25.08 | 16,626 | D | — | — | |
| 2 | Common | Ordinary Shares | 2022-02-21 | M | A | 6,875 | — | 23,501 | D | — | — | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. |
| 3 | Common | Ordinary Shares | 2022-02-21 | F | D | 2,022 | $25.08 | 21,479 | D | — | — | |
| 4 | Common | Ordinary Shares | 2022-02-22 | M | A | 12,037 | — | 33,516 | D | — | — | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. |
| 5 | Common | Ordinary Shares | 2022-02-20 | M | A | 10,096 | — | 19,592 | D | — | — | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. |
| 6 | Common | Ordinary Shares | 2022-02-22 | F | D | 3,539 | $25.01 | 29,977 | D | — | — | |
| 7 | Common | Ordinary Shares | 2022-02-18 | S | D | 2,306 | $25.17 | 9,496 | D | — | — | |
| 8 | Derivative | Restricted Stock Unit Award | 2022-02-21 | M | D | 6,875 | — | 6,875 | D | $0.00 · — to — | 6,875 Ordinary Shares | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. (F6) Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/21/2020. |
| 9 | Derivative | Restricted Stock Unit Award | 2022-02-22 | M | D | 12,037 | — | 36,114 | D | $0.00 · — to — | 12,037 Ordinary Shares | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. (F7) Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/22/2022. |
| 10 | Derivative | Restricted Stock Unit Award | 2022-02-18 | A | A | 34,889 | $0.00 | 34,889 | D | $0.00 · — to — | 34,889 Ordinary Shares | (F4) Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/18/2023. |
| 11 | Derivative | Employee Stock Option (Right to Buy) | 2022-02-18 | A | A | 139,554 | $0.00 | 139,554 | D | $25.08 · — to 2032-02-18 | 139,554 Ordinary Shares | (F3) Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023. |
| 12 | Derivative | Restricted Stock Unit Award | 2022-02-20 | M | D | 10,096 | — | 20,191 | D | $0.00 · — to — | 10,096 Ordinary Shares | (F2) Restricted stock units convert into ordinary shares on a one-for-one basis. (F5) Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/20/2021. |